ORKA EPS Estimates
Oruka Therapeutics, Inc.
$74.61
+$2.67(+3.72%)
39
Overall
45
Value
45
Tech
28
Quality
Market Cap
$4.76B
Volume
277.22K
52W Range
$25.11 - $115.52
Target Price
$145.21
ORKA EPS estimates: the consensus estimate for Oruka Therapeutics, Inc.'s current fiscal year is -$2.42 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ORKA EPS Estimates
- EPS estimate, current quarter
- $-0.68
- EPS estimate, next quarter
- $-0.67
- EPS estimate, current year
- $-2.42
- EPS estimate, next year
- $-2.93
- EPS growth, 3-year
- +51.95%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.85 |
| 2023 | $-4.44 |
| 2022 | $-8.28 |
| 2021 | $-16.68 |
| 2020 | $-24.84 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORKA | $74.61 | +3.7% | 277.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Oruka Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW